|
´ëÇÑÄ¡°ú¼ö¸éÇÐȸ ȸ¿øÀÌ Áö³ 7~8ÀÏ ÀÌƲ°£ ¹é¹ü±â±¸±â³ä°ü¿¡¼ ´ëÇѼö¸éÇÐȸ°¡ ÁÖÃÖÇÑ ´ëÇѼö¸éÇÐȸ Á¤±âÇмú´ëȸ¿¡ Âü¿©ÇØ ¹ßÇ¥ÇÏ°í ÀÖ´Ù. |
´ëÇÑÄ¡°ú¼ö¸éÇÐȸ(ȸÀå Á¤Áø¿ì) ȸ¿øµéÀÌ Áö³ 7~8ÀÏ ÀÌƲ°£ ¹é¹ü±â±¸±â³ä°ü¿¡¼ ´ëÇѼö¸éÇÐȸ°¡ ÁÖÃÖÇÑ 2019³â Á¦14ȸ ´ëÇѼö¸éÇÐȸ Á¤±âÇмú´ëȸ¿¡ Âü¿©Çß´Ù.
¼ö¸éÇÐȸ´Â 2018³â 7¿ù 1ÀϺÎÅÍ ½ÃÀÛµÈ ¼ö¸é´Ù¿ø°Ë»ç¿Í ¾ç¾ÐÄ¡·áÀÇ º¸ÇèÈ·Î ÀÎÇØ °ü½ÉÀÌ ÁýÁߵǰí ÀÖÀ¸¸ç, ¼ö¸é½ÃÀåµµ Æø¹ßÀûÀ¸·Î Áõ°¡ÇÏ´Â Ãß¼¼ÀÌ´Ù.
ÀÌ·¯ÇÑ Ãß¼¼¸¦ ¹Ý¿µÇϵí Á¦14ȸ ¼ö¸éÇÐȸ ½ÉÆ÷Áö¾öÀº ¼ö¸éÀÇÇÐÀÇ ÃÖ½ÅÁö°ßÀ̳ª °íÀüÀûÀ¸·Î Áß¿ä Æ÷ÀÎÆ®µéÀ» Æ÷°ýÀûÀ¸·Î ´Ù·ç¾úÀ¸¸ç, ¼ö¸éÁúȯÀ» ´Ù·ç´Â ÀÓ»ó°¡ ÀÇ·áÀÎ»Ó ¾Æ´Ï¶ó ±âÃÊÀÇÇÐÀÚ ÀÓ»óº´¸®»ç ¼ö¸é»ê¾÷ °ü°èÀÚ µî 500¿©¸íÀÌ Âü¼®ÇØ ¼ºÈ²À» ÀÌ·ð´Ù.
´ëÇÑÄ¡°ú¼ö¸éÇÐȸ´Â ¼ö¸éÀÇÇаú ȯÀÚÄ¡·á¿¡¼ Ä¡°úºÐ¾ßÀÇ Áß¿ä ¿ªÇÒ°ú ¿¬±¸µéÀ» ¼Ò°³ÇÏ°íÀÚ ÇÐȸ¿¡ Âü¿©Çß´Ù. Çѱ¹¿¡¼ ÀÌ·ç¾îÁö°í ÀÖ´Â ÇØ´çºÐ¾ß Ä¡·á¿¡ ´ëÇÑ °æÇè ÀÓ»ó Áö½Ä ¿¬±¸µéÀ» È°¹ßÇÏ°Ô ¹ßÇ¥ÇÏ¿© ÁÁÀº È£ÀÀÀ» À̲ø¾î ³Â´Ù. ƯÈ÷ ¿ÃÇØ´Â Ä¡°úºÐ¾ß¿¡¼ Special interest groupÀ¸·Î ¼¼¼ÇÀ» µû·Î ¿î¿µÇß´Ù.
Special interest group 2: Choosing oral appliance treatment responders ¼¼¼Ç (ÁÂÀå: °æºÏ´ëÇб³ ±¸°³»°ú ÃÖÀç°© ±³¼ö)¿¡¼ ¢¹Ã¹¹ø° ¿¬ÀÚ ÀÌ¿¬Èñ ±³¼ö(°æÈñ´ë ±¸°³»°ú)°¡ ¡®Outcome prediction through PSG data¡¯¸¦ ÁÖÁ¦·Î °¿¬Çß°í, ÀÌ¾î ¢¹ÀÓÇö´ë ±³¼ö(¿ø±¤´ë ±¸°³»°ú)ÀÇ ¡®Outcome prediction through imaging study (CFD, endoscopy) ¢¹ÀåÁöÈñ ±³¼ö(¼¿ï´ë ±¸°³»°ú)ÀÇ ¡®Other predictors (spirometry, single-night titration, loop gain etc)°¡ À̾îÁ³´Ù.
´ëÇÑÄ¡°ú¼ö¸éÇÐȸ ¼Ò¼ÓÀÎ ¢¹±Ç¿ë´ë ±³¼ö(°æÈñ´ë ±¸°¿Ü°ú)ÀÇ ¡®Maxillo-mandibular advancement surgery: indication, technique, complication¡¯, ¢¹±èÇý°æ ±³¼ö(´Ü±¹´ë ±¸°³»°ú)ÀÇ ¡®Oral examination for oral appliance¡¯¸¦ °¿¬ÇÏ¿©, ´Ùä·Î¿î ¼ö¸éÀå¾Ö ȯÀÚ¿¡ ´ëÇÑ ´Ùä·Î¿î Ä¡°úÀû Á¢±ÙÀ» ¼Ò°³Çß´Ù. ±è¼ºÅà ±³¼ö(¿¬¼¼´ë ±¸°³»°ú)°¡ ÁÂÀåÀ» ¸ÃÀº Management of patients with mild to moderate OSA ¼¼¼Ç¿¡¼´Â ¢¹±è°æ¾Æ ±³¼ö (°æÈñ´ë ±³Á¤°ú)ÀÇ ¡®Oral appliance in mild to moderate OSA¡¯ °¿¬ÀÌ ÆîÃÄÁ³´Ù. ÀÌƲ°£ÀÇ ÇÐȸ±â°£µ¿¾È Ä¡°úºÐ¾ß¿¡¼´Â ´Ù¾çÇÑ ÁÖÁ¦¸¦ ¼±º¸¿© ´ëÇѼö¸éÇÐȸ¿¡¼ ÁÁÀº È£ÀÀÀ» À̲ø¾î³Â´Ù.